Results 101 to 110 of about 11,222 (199)

Bioavailability and disposition of azelastine and fluticasone propionate when delivered by MP29‐02, a novel aqueous nasal spray [PDF]

, 2012
Hartmut Derendorf, Ullrich Munzel, U. Petzold, Joachim Maus, Hermann Mascher, Róbert Hermann, Jean Bousquet   +6 more
openalex   +1 more source

P122 Combination therapy with inhaled salmeterol plus fluticasone propionate is more effective than salmeterol alone in reducing the risk of clinically important deterioration in COPD: A post-hoc analysis of the TORCH trial: Abstract P122 Table 1 [PDF]

, 2015
Ian Naya, Lee Tombs, Paul Jones
openalex   +1 more source

Patient-reported outcomes in clinical trials of inhaled asthma medications: systematic review and research needs

, 2011
Numerous validated PRO instruments are available but it is unclear why few are used in asthma clinical trials. Problems include poor reporting, and uncritical analysis and interpretation of PRO scores.
Frampton, Geoff, Shepherd, Jonathan
core   +1 more source

The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers

, 2023
Wenyuan Qi, Yue Liu, Wei Xue, Kexin Li, J. Christopher Gorski, Mark Liu, Tieliang Yan, Duc Tung Nguyen, Rajesh Kumar Ramalingam   +8 more
openalex   +2 more sources

Salmeterol and Fluticasone Propionate (50/250 μg) Administered via Combination Diskus Inhaler: As Effective as When Given via Separate Diskus Inhalers

Canadian Respiratory Journal, 1999
OBJECTIVE: To compare the efficacy and safety of a new combination Diskus inhaler containing both salmeterol 50 μg and fluticasone propionate 250 μg (Seretide) with the two drugs delivered via separate Diskus inhalers.
Kenneth R Chapman, Nils Ringdal, Vibeke Backer, Mona Palmqvist, Seppo Saarelainen, Mark Briggs   +5 more
doaj   +1 more source

Randomized, double-blind trial evaluating the efficacy and safety of fluticasone propionate and fluticasone propionate/salmeterol delivered via multidose dry powder inhalers in patients with persistent asthma aged 12 years and older [PDF]

, 2017
Gordon Raphael, Gloria Yiu, Anat Sakov, Siyu Liu, Cynthia Caracta   +4 more
openalex   +1 more source

The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)

International Journal of COPD, 2016
Kai-Michael Beeh,1 Eric Derom,2 José Echave-Sustaeta,3 Lars Grönke,4 Alan Hamilton,5 Dongmei Zhai,6 Leif Bjermer71Insaf GmbH Institut für Atemwegsforschung, Wiesbaden, Germany; 2Department of Internal Medicine, Ghent University Hospital,
Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L   +6 more
doaj  

Onset of Action and Pharmacokinetic Parameters of Azelastine Hydrochloride in Azelastine Nasal Spray and in a Combination Nasal Spray with Fluticasone Propionate [PDF]

, 2009
R. Berkowitz, Susan Braker, L. Fredane, Harry Sacks   +3 more
openalex   +1 more source

Effects of nasal corticosteroids on boosts of systemic allergen-specific IgE production induced by nasal allergen exposure.

PLoS ONE, 2015
BackgroundAllergen exposure via the respiratory tract and in particular via the nasal mucosa boosts systemic allergen-specific IgE production. Intranasal corticosteroids (INCS) represent a first line treatment of allergic rhinitis but their effects on ...
Cornelia Egger, Christian Lupinek, Robin Ristl, Patrick Lemell, Friedrich Horak, Petra Zieglmayer, Susanne Spitzauer, Rudolf Valenta, Verena Niederberger   +8 more
doaj   +1 more source

Cost-effectiveness of fluticasone propionate/salmeterol (500/50μg) in the treatment of COPD [PDF]

, 2008
Stephanie Earnshaw, Michele Wilson, Anand A. Dalal, Mike Chambers, Priti Jhingran, Richard H. Stanford, Douglas W. Mapel   +6 more
openalex   +1 more source